These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29050806)

  • 1. Immune checkpoint inhibitor-associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis?
    Strik H; Keber U; Hammoud WA; Riera-Knorrenschild J; Carl B; Dodel R; Pagenstecher A; Neubauer A
    Eur J Cancer; 2017 Dec; 87():205-208. PubMed ID: 29050806
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer.
    Williams TJ; Benavides DR; Patrice KA; Dalmau JO; de Ávila AL; Le DT; Lipson EJ; Probasco JC; Mowry EM
    JAMA Neurol; 2016 Aug; 73(8):928-33. PubMed ID: 27271951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case Report of Steroid Responsive Nivolumab-Induced Encephalitis.
    Richard K; Weslow J; Porcella SL; Nanjappa S
    Cancer Control; 2017; 24(5):1073274817729069. PubMed ID: 28975824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Adenosine Deaminase Levels in the Cerebrospinal Fluid in Immune Checkpoint Inhibitor-induced Autoimmune Encephalitis.
    Fujiwara S; Mimura N; Yoshimura H; Fujimoto D; Ito M; Mori R; Ito J; Tomii K; Kawamoto M; Kohara N
    Intern Med; 2019 Oct; 58(19):2871-2874. PubMed ID: 31243206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune Encephalitis Related to Cancer Treatment With Immune Checkpoint Inhibitors: A Systematic Review.
    Nersesjan V; McWilliam O; Krarup LH; Kondziella D
    Neurology; 2021 Jul; 97(2):e191-e202. PubMed ID: 33952651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial fibrillary acidic protein (GFAP) associated autoimmune meningoencephalitis in a patient receiving nivolumab.
    Kapadia RK; Ney DE; Hannan M; Farley M; Pastula DM; Piquet AL
    J Neuroimmunol; 2020 Jul; 344():577259. PubMed ID: 32416558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of de novo palmoplantar psoriasis with psoriatic arthritis and autoimmune hypothyroidism after receiving nivolumab therapy.
    Elosua-González M; Pampín-Franco A; Mazzucchelli-Esteban R; Mielgo-Rubio X; Rodriguez-Vásquez X; García-Zamora E; López-Estebaranz JL
    Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent autoimmune encephalitis related to immune checkpoint inhibitors.
    Ser MH; Samanci NŞ; Ak N; Aydiner A; Özkara Ç
    Epileptic Disord; 2022 Jun; 24(3):609-613. PubMed ID: 35770759
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-PD-1 Antibody Therapy Induces Hashimoto's Disease with an Increase in Peripheral Blood Follicular Helper T Cells.
    Torimoto K; Okada Y; Nakayamada S; Kubo S; Tanaka Y
    Thyroid; 2017 Oct; 27(10):1335-1336. PubMed ID: 28699391
    [No Abstract]   [Full Text] [Related]  

  • 10. Bilateral Thalamic Lesions Associated With Atezolizumab-Induced Autoimmune Encephalitis.
    Nishijima H; Suzuki C; Kon T; Nakamura T; Tanaka H; Sakamoto Y; Tomiyama M
    Neurology; 2021 Jan; 96(3):126-127. PubMed ID: 33268558
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiolabeled anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoma.
    Dillman RO
    J Clin Oncol; 2002 Aug; 20(16):3545-57. PubMed ID: 12177115
    [No Abstract]   [Full Text] [Related]  

  • 12. Neutropenia in patients treated with rituximab.
    Voog E; Morschhauser F; Solal-Céligny P
    N Engl J Med; 2003 Jun; 348(26):2691-4; discussion 2691-4. PubMed ID: 12826650
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody-negative autoimmune encephalitis as a complication of long-term immune-suppression for liver transplantation.
    Spindel J; Heckroth M; Marsano L
    BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32933909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological aggravation of autoimmune thyroid disease in two cases receiving nivolumab.
    Narita T; Oiso N; Taketomo Y; Okahashi K; Yamauchi K; Sato M; Uchida S; Matsuda H; Kawada A
    J Dermatol; 2016 Feb; 43(2):210-4. PubMed ID: 26198822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Checkpoint inhibitor-induced autoimmune encephalitis reversed by rituximab after allogeneic bone marrow transplant in a patient with Hodgkin lymphoma.
    Thummalapalli R; Sena LA; Probasco JC; Gladstone DE
    Leuk Lymphoma; 2020 Jan; 61(1):228-230. PubMed ID: 31502489
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatal central nervous system lesions emerging during anti-CD20 monoclonal antibody therapy (Rituximab) for a post transplantation Epstein Barr virus-linked lymphoma.
    Sirvent-Von Bueltzingsloewen A; Sirvent N; Morand P; Cassuto JP
    Med Pediatr Oncol; 2003 Jun; 40(6):408-9. PubMed ID: 12692818
    [No Abstract]   [Full Text] [Related]  

  • 17. HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy.
    Pitini V; Sturniolo G; Arrigo C; Leonardi S; Pino S; Altavilla G
    Br J Haematol; 2010 Jul; 150(1):116-8. PubMed ID: 20230413
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of rituximab-related urticarial reaction in cutaneous B-cell lymphoma.
    Rey J; Wickenhauser S; Ivanov V; Coso D; Gastaut JA; Bouabdallah R
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):210. PubMed ID: 18482321
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab in diffuse large B-cell lymphoma.
    Coiffier B
    Clin Adv Hematol Oncol; 2004 Mar; 2(3):156-7. PubMed ID: 16166943
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal antibodies and cytomegalovirus infections.
    Damaj G; Charbonnier A; Bouabdallah R; Vey N; Coso D; Stoppa AM; Gastaut JA
    Eur J Haematol; 2004 Jul; 73(1):73-4. PubMed ID: 15182343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.